Actemra 400 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQQ9X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,387
Award facts
- Contract value 100% obligated
- $39,386.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $39,386.96 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on November 28, 2025, with an ultimate completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
Actemra is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions, representing the type of specialized pharmaceutical commodity that DLA procures to support military healthcare programs and the Defense Health Agency. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its established capability to supply a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to military and veteran healthcare systems. This delivery order exemplifies the company's role as a key pharmaceutical prime vendor supporting the global medical supply chain for Department of Defense beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FQQ9X?
SPE2DR26FQQ9X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FQQ9X worth?
The government has obligated $39,387 on SPE2DR26FQQ9X.
Is contract SPE2DR26FQQ9X an order under another contract?
Yes. SPE2DR26FQQ9X is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ9X competed?
The extent of competition for SPE2DR26FQQ9X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award